BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 11500061)

  • 1. Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis.
    Boige V; Castéra L; de Roux N; Ganne-Carrié N; Ducot B; Pelletier G; Beaugrand M; Buffet C
    Gut; 2003 Aug; 52(8):1178-81. PubMed ID: 12865278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of new-onset cancer associated with HFE C282Y and H63D mutations: evidence from 87,028 participants.
    Lv YF; Chang X; Hua RX; Yan GN; Meng G; Liao XY; Zhang X; Guo QN
    J Cell Mol Med; 2016 Jul; 20(7):1219-33. PubMed ID: 26893171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the Influence of the Iron Regulatory MHC Class I Molecule HFE on Tumor Progression in Experimental Models and Clinical Populations.
    Weston C; Connor J
    Transl Oncogenomics; 2014; 6():1-12. PubMed ID: 25520556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of primary and secondary liver cancers.
    Ananthakrishnan A; Gogineni V; Saeian K
    Semin Intervent Radiol; 2006 Mar; 23(1):47-63. PubMed ID: 21326720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-viral causes of hepatocellular carcinoma.
    Blonski W; Kotlyar DS; Forde KA
    World J Gastroenterol; 2010 Aug; 16(29):3603-15. PubMed ID: 20677332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between C282Y and H63D mutations of the HFE gene with hepatocellular carcinoma in European populations: a meta-analysis.
    Jin F; Qu LS; Shen XZ
    J Exp Clin Cancer Res; 2010 Mar; 29(1):18. PubMed ID: 20196837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HFE gene in primary and secondary hepatic iron overload.
    Sebastiani G; Walker AP
    World J Gastroenterol; 2007 Sep; 13(35):4673-89. PubMed ID: 17729389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The irony of herbal hepatitis: Ma-Huang-induced hepatotoxicity associated with compound heterozygosity for hereditary hemochromatosis.
    Bajaj J; Knox JF; Komorowski R; Saeian K
    Dig Dis Sci; 2003 Oct; 48(10):1925-8. PubMed ID: 14627335
    [No Abstract]   [Full Text] [Related]  

  • 9. [Genetic hemochromatosis and the HFE gene].
    Moirand R
    Bull Acad Natl Med; 2000; 184(2):325-35; discussion 335-6. PubMed ID: 10989541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis.
    Bonkovsky HL; Obando JV
    Curr Gastroenterol Rep; 1999; 1(1):30-7. PubMed ID: 10980924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma.
    Fargion S; Stazi MA; Fracanzani AL; Mattioli M; Sampietro M; Tavazzi D; Bertelli C; Patriarca V; Mariani C; Fiorelli G
    Blood Cells Mol Dis; 2001; 27(2):505-11. PubMed ID: 11500061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
    Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
    Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma.
    Lauret E; Rodríguez M; González S; Linares A; López-Vázquez A; Martínez-Borra J; Rodrigo L; López-Larrea C
    Am J Gastroenterol; 2002 Apr; 97(4):1016-21. PubMed ID: 12003382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.
    Fracanzani AL; Fargion S; Stazi MA; Valenti L; Amoroso P; Cariani E; Sangiovanni A; Tommasini M; Rossini A; Bertelli C; Fatta E; Patriarca V; Brescianini S; Stroffolini T
    Blood Cells Mol Dis; 2005; 35(1):27-32. PubMed ID: 15894495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver.
    Blanc JF; De Ledinghen V; Bernard PH; de Verneuil H; Winnock M; Le Bail B; Carles J; Saric J; Balabaud C; Bioulac-Sage P
    J Hepatol; 2000 May; 32(5):805-11. PubMed ID: 10845668
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.